Caristo Diagnostics Welcomes Stephen Deitsch as New CEO to Drive Growth in Cardiovascular AI Technology Caristo Diagnostics has appointed Stephen Deitsch as their new CEO. With extensive experience in medtech, Deitsch aims to enhance the company’s innovations in cardiovascular disease prevention.

Caristo Diagnostics Welcomes Stephen Deitsch as New CEO to Drive Growth in Cardiovascular AI Technology #United_Kingdom #Oxford #AI_Technology #Caristo_Diagnostics #Stephen_Deitsch

Final Medicare Reimbursement for Caristo's CaRi-Plaque Set to Advance Cardiovascular Care Caristo Diagnostics announces the finalization of Medicare reimbursement for its CaRi-Plaque technology, enhancing access to advanced cardiovascular disease diagnostics across the U.S.

Final Medicare Reimbursement for Caristo's CaRi-Plaque Set to Advance Cardiovascular Care #United_States #Stamford #Caristo_Diagnostics #CaRi-Plaque #Medicare_Reimbursement

Caristo Diagnostics Selected as Global Imaging Lab for Groundbreaking Heart Trial Caristo Diagnostics has been appointed as the worldwide imaging core lab for an innovative cardiovascular study by NewAmsterdam Pharma, enhancing diagnosis and treatment methods.

Caristo Diagnostics Selected as Global Imaging Lab for Groundbreaking Heart Trial #United_States #Stamford #Caristo_Diagnostics #cardiovascular_study #REMBRANDT_trial

Biograph and Caristo Collaborate for Breakthrough in Heart Health with AI Study Biograph partners with Caristo Diagnostics to launch an innovative U.S. study focusing on early heart disease detection using AI technology and cardiac CT scans.

Biograph and Caristo Collaborate for Breakthrough in Heart Health with AI Study #United_States #Caristo_Diagnostics #Heart_Health #Biograph #San_Mateo,_Stamford

Caristo Applauds Abcentra's Successful First Patient Dosing in Phase 2b FORTIFY Trial for Cardiovascular Disease Caristo Diagnostics congratulates Abcentra on the successful dosing of the first patient in the Phase 2b FORTIFY trial, a crucial step in evaluating orticumab for cardiovascular patients.

Caristo Applauds Abcentra's Successful First Patient Dosing in Phase 2b FORTIFY Trial for Cardiovascular Disease #USA #Stamford #Caristo_Diagnostics #Abcentra #Orticumab

Revolutionary FAI-Score Technology Demonstrates Superior Predictive Power for Cardiac Death at ESC 2025 Congress Caristo Diagnostics unveiled groundbreaking findings at ESC 2025, showcasing the FAI-Score's predictive strength for cardiac death, surpassing traditional methods.

Revolutionary FAI-Score Technology Demonstrates Superior Predictive Power for Cardiac Death at ESC 2025 Congress #United_Kingdom #Oxford #Caristo_Diagnostics #ESC_Congress #FAI-Score

Caristo Expected to Break New Ground in Cardiac Risk Assessment at SCCT 2025 At the upcoming SCCT 2025, Caristo Diagnostics will reveal groundbreaking findings about cardiac risk assessment using their innovative CaRi-Heart technology.

Caristo Expected to Break New Ground in Cardiac Risk Assessment at SCCT 2025 #United_States #Montreal #Caristo_Diagnostics #CaRi-Heart #SCCT_2025

Caristo's FDA Clearance Marks a Milestone for AI in Heart Attack Prevention Caristo Diagnostics has received FDA 510(k) clearance for its CaRi-Plaque™ technology, transforming heart attack prevention with AI-driven diagnostics.

Caristo's FDA Clearance Marks a Milestone for AI in Heart Attack Prevention #USA #Stamford #Heart_Disease #Caristo_Diagnostics #CaRi-Plaque

Michel Lussier Appointed to Caristo Diagnostics Board to Enhance Cardiovascular Innovations Caristo Diagnostics welcomes Michel Lussier to its board, enhancing the company's expertise in cardiovascular technology. His experience promises to drive innovative diagnostics.

Michel Lussier Appointed to Caristo Diagnostics Board to Enhance Cardiovascular Innovations #Oxford #UK #digital_health #Caristo_Diagnostics #Michel_Lussier

Caristo Diagnostics Revolutionizes Cardiovascular Health with Award-Winning Technology Caristo Diagnostics has transformed cardiovascular risk prediction with its innovative technology, winning the Fierce Healthcare Innovation Awards 2024.

Caristo Diagnostics Revolutionizes Cardiovascular Health with Award-Winning Technology #United_Kingdom #Oxford #Cardiovascular_Health #Caristo_Diagnostics #CaRi-Heart